drugset / Trial / NCT01831193

Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease

NCT01831193

Phase 3 Completed 120 enrolled Instituto Nacional de Cardiologia Ignacio Chavez
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if the oral supplementation with curcumin reduces proteinuria in patients with chronic kidney disease regardless the ethiology.

Timeline

Start
2013-02
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Curcumin Small molecule Oral

Indications